Boosters from Omicron reduced the hospitalization of the elderly by 81%

News » Health "Omikron"

A study of updated Pfizer vaccines released in the summer found that they reduced the risk of death in this demographic by about 86%.
The study is the world's first large-scale evaluation of “bivalent” However, this does not shed light on how much more effective the new vaccines are compared to the original vaccines before they were updated against Omicron.

“The bottom line is, if you are 65 or older, booster shots can give you extra protection,” – says Dr. Ronen Arbel, author of the study. “This extra protection is in addition to previous shots and can keep you out of hospital and save your life.”

While the study focused on Pfizer's vaccines, it also shows Moderna's effectiveness, because the technology is similar, according to Arbel. and vaccinations are equally effective.

The study called bivalent boosters “an effective and important tool”; to reduce the risk of death and illness from COVID in the age group over 65 years. Dr. Arbel believes they are of “global significance”.

Dr. Doron Netzer, head of the medical department at Clalit Health Services, Israel's largest health care provider, and one of the authors of the study, said the study was encouraging given that the bivalent vaccine was presented with limited data on its effectiveness.

largely associated with a reduced risk of hospitalization deaths and coronavirus deaths, including many of the current Omicron strains. The Israeli health ministry's decision to recommend an extra dose of the vaccine to the elderly population has prevented many hospitalizations and even deaths from the coronavirus. Publication of the results of the study could help convince populations at risk to complete this beneficial vaccine, – said Netzer.

Follow us on Telegram

Add a Comment

Your email address will not be published. Required fields are marked *